-
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart FailureESJ Tan, S-P Chan, O-W Liew et al. -
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of AmericaDunlay SM, Givertz MM, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America.
-
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF RegistriesKi Hong Choi Jin‐Oh Choi et al.
-
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)DP Leong, JJV McMurray, PG Joseph et al.
-
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection FractionJ Tromp, L Shen, PS Jhund et al.
-
Mechanical circulatory support devices for acute right ventricular failureKapur NK, Esposito ML, Bader Y et al.
-
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart FailureFelker GM, Ahmad T, Anstrom KJ et al.
-
Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) TrialB Pieske, MJ Patel, VICTORIA Study Group et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
